| 
				健保碼及健保價 | 
		 
		
			| 
				See related Multaq film-coated tab[脈泰克 膜衣錠] information | 
		 
		
			| 
				  | 
		 
		
			| 
				製造商 | 
			
				Sanofi-aventis | 
		 
		
			| 
				代理/經銷商 | 
			
				Sanofi-aventis | 
		 
		
			| 
				成份 | 
			
				Dronedarone HCl | 
		 
		
			| 
				適應症 | 
			
				Treatment of atrial fibrillation (AF) or arterial flutter (AFL), with a recent episode of AF/AFL & associated CV risk factors (age >70, HTN, diabetes, prior cerebrovascular accident, left atrial diameter ≥50 mm or left ventricular ejection fraction [LVEF] <40%), who are in sinus rhythm or who will be cardioverted. | 
		 
		
			| 
				用量 | 
			
				Adult 400 mg bid. | 
		 
		
			| 
				過量 | 
			
				View Multaq[脈泰克] overdosage for action to be taken in the event of an overdose. | 
		 
		
			| 
				用法 | 
			
				Should be taken with food (Avoid grapefuit juice.). | 
		 
		
			| 
				禁忌 | 
			
				Severe CHF (Stage NYHA IV) & other unstable hemodynamic conditions; 2nd- or 3rd-degree AV block or sick sinus syndrome (except when used in conjunction with a functioning pacemaker); bradycardia <50 bpm; co-administration with strong CYP3A4 inhibitors eg ketoconazole, itraconazole, voriconazole, cyclosporin, telithromycin, clarithromycin, nefazodone & ritonavir; co-administration with drugs inducing torsades de pointes eg phenothiazines, tricyclic antidepressants, certain oral macrolides, class I & III antiarrhythmics; QTc Bazett interval ≥500 msec; severe hepatic impairment. Pregnancy & lactation. | 
		 
		
			| 
				注意事項 | 
			
				May induce QT prolongation. Patients with moderate CHF (Stage NYHA III). Correct K or Mg deficiency before & during therapy. Monitor plasma creatinine. | 
		 
		
			| 
				不良反應 | 
			
				Diarrhea, nausea, vomiting, fatigue, asthenia, abdominal pain, dyspepsia, bradycardia, rashes, pruritis. 
				View ADR Monitoring Website[參閱藥物不良反應監測表格] | 
		 
		
			| 
				交互作用 | 
			
				β-blockers, Ca antagonists, digoxin; phenothiazines, bepridil, TCAs, certain oral macrolides, class I & III antiarrhythmics; doxorubicin, fexofenadine, talinolol; rifampicin, phenobarbital, carbamazepine, phenytoin; ketoconazole, itraconazole, voriconazole, ritonavir, cyclosporin, telithromycin, clarithromycin; sirolimus & tacrolimus; simvastatin, lovastatin, atorvastatin, pravastatin; theophylline; warfarin 
				View more drug interactions with Multaq[脈泰克] | 
		 
		
			| 
				儲存 | 
			
				View Multaq[脈泰克] storage conditions for details to ensure optimal shelf-life. | 
		 
		
			| 
				描述 | 
			
				View Multaq[脈泰克] description for details of the chemical structure and excipients (inactive components). | 
		 
		
			| 
				作用 | 
			
				View Multaq[脈泰克] mechanism of action for pharmacodynamics and pharmacokinetics details. | 
		 
	
 
 
	
		
			| 
				本商品之市售規格 | 
		 
		
			| 
				
				 | 
		 
		
			
				
					
						
							
								
									
										
											| 
												Manufacturer: | 
											
												Sanofi-aventis | 
										 
										
											| 
												Distributor: | 
											
												Sanofi-aventis | 
										 
									
								 
							 | 
							
								  | 
						 
					
				 
			 | 
		 
	
 
 |